Similarly, another group demonstrated that severe COVID-19 patients exhibited higher frequencies of CD39+CD4+ T-cells and diminished frequencies of CD73+CD4+ and CD73+CD8+ T-cells in comparison with mild COVID-19 patients and healthy controls (28). This evidence concerns the gene ENTPD1 and COVID-19.